Anti-Siglec-4a/MAG Antibody (Refanezumab)
Catalog No.
F1755
Anti-Siglec-4a/MAG Antibody (Refanezumab)
Featured Products
Refanezumab (GSK249320) is an IgG1 humanized monoclonal antibody against myelin-associated glycoprotein (MAG). Refanezumab binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab can cross the blood-brain barrier (BBB) in animal stroke models. Refanezumab has the potential to be used in studies to enhance functional recovery after stroke.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
148.36 kDa
Dry ice
1233953-61-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
GSK 249320, GSK249320
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P20916
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human Siglec 4a / MAG, Fc Tag at 2 ug/mL can bind Anti-Siglec-4a/MAG Antibody (Refanezumab)
Siglec-4a / MAG
Please avoid freeze-thaw cycles.